About the Company
Repligen is an American company devoted to the development and production of materials used in the manufacture of biological drugs.2014 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, about 50% of these based in Sweden.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $RGEN News
Should be Confident in Repligen Corporation (RGEN)’s Long-Term Growth Potential?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A ...
Thermo Fisher Claims Competitor Repligen Poaches Employees
Thermo Fisher Scientific Inc. accused life sciences company Repligen Corp. of violating state consumer protection laws by ...
Artisan Mid Cap Fund Trimmed Repligen Corporation (RGEN) after Share Appreciation
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A ...
Repligen to Report First Quarter 2024 Financial Results
WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2024 financial results on Wednesday, May 1, 2024.
Carmel Man Accused Of Sending “Creepy” Messages Wanting Sex From Underage Girls
A man in Carmel is in jail accused of trying to solicit underage girls for sex. Craig Levinson, 52, who is married and is a ...
Positive Report for Repligen (RGEN) from Craig-Hallum
Repligen (RGEN – Research Report) received a Buy rating and price target from Craig-Hallum analyst Matt Hewitt today. The ...
Baron Health Care Fund Q1 2024 Shareholder Letter
We added to Repligen Corporation (RGEN), a life science tools supplier that offers a broad portfolio of tools involved in the production of biologic drugs, including upstream cell culture ...
Repligen Corp RGEN
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Relative Strength Alert For Repligen
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Repligen Corp. (Symbol: RGEN) entered into oversold territory, hitting an RSI reading of 29 ...
Loading the latest forecasts...